Cytomegalovirus Thrombophlebitis After Successful DHPG Therapy
- POWERS PETERSON, M.D.; and
- CELINE M. STAHL-BAYLISS, M.D.
- Cornell University Medical College; New York, NY 10021
- Memorial Sloan Kettering Cancer Center; New York, NY 10021
Excerpt
To the editor: Cytomegalovirus is a frequent cause of opportunistic infections in patients with the acquired immunodeficiency syndrome (AIDS) (1). 9-[1,3-dihydroxy-2-propoxy)methyl]guanine (DHPG) is a new, potent, and broadly active antiherpetic agent structurally similar to acyclovir. It was administered intravenously for 2 weeks to a male homosexual patient with persistent cytomegalovirus viremia. He was free of cytomegalovirus infection for 1 year and then developed a unique, previously unreported complication, cytomegalovirus thrombophlebitis.
A 34-year-old white homosexual man was diagnosed with AIDS in November 1983, when Kaposi sarcoma was histologically confirmed. He remained well until November 1984, when he developed low-grade fevers, diffuse
This 100-word excerpt has been provided in the absence of an abstract.
RSS Feeds









